Abstract:Mai Zhang, 1 Yan Li, 1, 2 Chunli Han, 3 Shiying Chu, 1 Peng Yu, 1 Wenbo Cheng 1, 2 1 Mass Spectrometry Application Center, Tianjin Guoke Medical Technology Development Co., Ltd, Tianjin, People's Republic of China; 2 Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences (CAS), Suzhou, People's Republic of China; 3 Mass Spectrometry Application Center, Shandong CAS Intelligent Manufacturing Medical Device Technology Co., Ltd, Zaozhuang, People's Republic of China Correspondence: Wenbo Cheng, Email Background: Inhibition of amyloid β protein fragment (Aβ) aggregation is considered to be one of the most effective strategies for the treatment of Alzheimer's disease. (-)-Epigallocatechin-3-gallate (EGCG) has been found to be effective in this regard; however, owing to its low bioavailability, nanodelivery is recommended for practical applications. Compared to chemical reduction methods, biosynthesis avoids possible biotoxicity and cumbersome preparation processes. Materials and Methods: The interaction between EGCG and Aβ 42 was simulated by molecular docking, and green tea-conjugated gold nanoparticles (GT-Au NPs) and EGCG-Au NPs were synthesized using EGCG-enriched green tea and EGCG solutions, respectively. Surface active molecules of the particles were identified and analyzed using various liquid chromatography-tandem triple quadrupole mass spectrometry methods. ThT fluorescence assay, circular dichroism, and TEM were used to investigate the effect of synthesized particles on the inhibition of Aβ 42 aggregation. Results: EGCG as well as apigenin, quercetin, baicalin, and glutathione were identified as capping ligands stabilized on the surface of GT-Au NPs. They more or less inhibited Aβ 42 aggregation or promoted fibril disaggregation, with EGCG being the most effective, which bound to Aβ 42 through hydrogen bonding, hydrophobic interactions, etc. resulting in 39.86% and 88.50% inhibition of aggregation and disaggregation effects, respectively. EGCG-Au NPs were not as effective as free EGCG, whereas multiple thiols and polyphenols in green tea accelerated and optimized heavy metal detoxification. The synthesized GT-Au NPs conferred the efficacy of diverse ligands to the particles, with inhibition of aggregation and disaggregation effects of 54.69% and 88.75%, respectively, while increasing the yield, enhancing water solubility, and decreasing cost. Conclusion: Biosynthesis of nanoparticles using green tea is a promising simple and economical drug-carrying approach to confer multiple pharmacophore molecules to Au NPs. This could be used to design new drug candidates to treat Alzheimer's disease. Keywords: gold nanoparticles, green synthesis, (-)-epigallocatechin-3-gallate, liquid chromatography tandem triple quadrupole mass spectrometry, amyloid β protein, green tea Alzheimer's disease (AD) is a neurodegenerative disease with insidious onset and progressive progression. The Alzheimer's Disease International (ADI) 2018 Global Report stated that every three seconds, someone in the world will develop dementia. 1 Currently, the pathogenesis of AD is highly controversial, but the main pathological hallmark is the misfolding of extracellular amyloid β-protein (Aβ) and neurofibrillary tangles induced by intracellular tau proteins. 2,3 Consequently, inhibition of Aβ aggregation is considered to be one of the most effective strategies for the treatment of AD. A variety of chemicals, including peptides, 4 curcumin, 5 alginate, 6 resveratrol, 7 and quercetin, 8 have been shown to inhibit Aβ fibrillation. Therein, (-)-epigallocatechin-3-gallate (EGCG), one of the most effective substances for inhibiting Aβ aggregation and promoting mature fiber disaggregation, 9–12 was achieved through the interaction of its own phenolic ring with the aromatic residues of Aβ by hydrogen bonding, aromatic stacking, and hydrophobicity. 13,14 Furthermore, in addition to chelating metal ions and scavenging free radicals, 15–17 Seidler et al revealed that EGCG could disaggregate brain-derived tau fibrils in vitro, fully validating the wide array of therapeutic potential of EGCG. 18 However, the applicability of EGCG in humans has encountered with rather limited success largely due to its low stability, poor blood–brain barrier (BBB) permeability, and rapid metabolic clearance, 19 ultimately resulting in an absolute bioavailability of only 0.1%. 20 Accordingly, diversified forms of EGCG delivery systems have been designed in the clinical setup. 21–25 Istenič et al utilized liposomes to -Abstract Truncated-

Design of Gallic Acid-Glutamine Conjugate and Chemical Implications for Its Potency Against Alzheimer's Amyloid- Fibrillogenesis

Gallic Acid Disruption of Aβ1–42 Aggregation Rescues Cognitive Decline of APP/PS1 Double Transgenic Mouse

Mannose‐rich Exopolysaccharide from Agaricus Sinodeliciosus Var. Chaidam: Purification, Chemical Characterization, and Neuroprotective Activity

Gallic Acid Alleviates Cognitive Impairment by Promoting Neurogenesis via the GSK3β-Nrf2 Signaling Pathway in an APP/PS1 Mouse Model

Ginnalin A Inhibits Aggregation, Reverses Fibrillogenesis, and Alleviates Cytotoxicity of Amyloid (1-42)

Pharmacodynamics in Alzheimer's Disease Model Rats of a Bifunctional Peptide with the Potential to Accelerate the Degradation and Reduce the Toxicity of Amyloid Β-Cu Fibrils.

Design, synthesis and anti-AD effects of dual inhibitor targeting glutaminyl cyclase/GSK-3β

Design, Synthesis of N-phenethyl Cinnamide Derivatives and Their Biological Activities for the Treatment of Alzheimer's Disease: Antioxidant, Beta-amyloid Disaggregating and Rescue Effects on Memory Loss.

Inhibition Mechanisms of (-)-epigallocatechin-3-gallate and Genistein on Amyloid-beta 42 Peptide of Alzheimer's Disease Via Molecular Simulations

Coassembly of Macrocyclic Amphiphiles for Anti-beta-Amyloid Therapy of Alzheimer's Disease

Nanogels Of Dual Inhibitor-Modified Hyaluronic Acid Function As A Potent Inhibitor Of Amyloid Beta-Protein Aggregation And Cytotoxicity

Guluronic acid can inhibit copper(II) and amyloid − β peptide coordination and reduce copper-related reactive oxygen species formation associated with Alzheimer's disease

Design, Synthesis, and Biological Evaluation of 2-Arylethenylquinoline Derivatives As Multifunctional Agents for the Treatment of Alzheimer's Disease.

Ganoderic Acid A Promotes Amyloid-β Clearance (In Vitro) and Ameliorates Cognitive Deficiency in Alzheimer’s Disease (Mouse Model) Through Autophagy Induced by Activating Axl

Compound (E)-2-(3,4-dihydroxystyryl)-3-hydroxy-4H-pyran-4-one downregulation of Galectin-3 ameliorates Aβ pathogenesis-induced neuroinflammation in 5 × FAD mice

Nanogels of dual inhibitor-modified hyaluronic acid function as a potent inhibitor of amyloid β-protein aggregation and cytotoxicity

Green Tea Extracts EGCG and EGC Display Distinct Mechanisms in Disrupting Aβ42 Protofibril.

Real-time Analysis of the Biomolecular Interaction Between Gelsolin Andaβ1-42 Monomer and Its Implication for Alzheimer's Disease

Molecular Mechanism of Cyanidin-3-O-Glucoside Disassembling Aβ Fibril in Silico

Ferrocene Tripeptide Gly-Pro-Arg Conjugates: Synthesis and Inhibitory Effects on Alzheimer’s Aβ1–42 Fibrillogenesis and Aβ-induced Cytotoxicity in Vitro

Biosynthesis of Nanoparticles with Green Tea for Inhibition of β-Amyloid Fibrillation Coupled with Ligands Analysis